Nath Bio-Genes (India) Ltd - 537291 - Audited Financial Results As Of 31St March 2023
Audited Financial Results as of 31st March 202322-04-2023
22-04-2023
Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Outcome for The Outcome Of The Board Meeting Held On 22Nd April 2023.
The outcome of the Board Meeting held on 22nd April 2023.22-04-2023
Nath Bio-Genes (India) Ltd - 537291 - Earning Conference Call Intimation.
Earning Conference Call of the Company to be held on 24th April 2023 at 04.00 PM.19-04-2023
Nath Bio-Genes (India) Ltd - 537291 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018, for the quarter ended 31st March 2023.17-04-2023
Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for To Consider And Approve Audited Financial Results For Quarter And Financial Year Ended 31St March 2023.
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/04/2023 ,inter alia, to consider and approve audited financial results for the quarter and financial year ended 31st March 2023.15-04-2023
Nath Bio-Genes (India) Ltd - 537291 - Compliance Certificate Under Reg 40 (10) As On 31St March 2023.
Compliance Certificate under Reg 40 (10) as on 31st March 2023.15-04-2023
Nath Bio-Genes (India) Ltd - 537291 - Compliance Certificate Under Reg 7(3).
Compliance Certificate under Reg 7(3).14-04-2023
Nath Bio-Genes (India) Ltd - 537291 - Closure of Trading Window
closure of the Trading window30-03-2023
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation on Unaudited financial results as on 31st December 2022.14-02-2023